List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 148 studies with search of: Ewing's Sarcoma
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study in Localized and Disseminated Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Zoledronic acid;   Drug: Busulfan;   Drug: Treosulfan
2 Completed Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Temozolomide;   Drug: L9-NC
3 Active, not recruiting Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
Condition: Ewing's Sarcoma
Interventions: Drug: Vincristine;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Dexrazoxane;   Biological: ImmTher
4 Completed Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
Condition: Non-Metastatic Ewings Sarcoma
Intervention:
5 Recruiting Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: busulfan;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Radiation: radiation therapy
6 Recruiting A Study to Determine the Activity of SCH 717454 in Subjects With Relapsed Osteosarcoma or Ewing's Sarcoma (Study P04720AM3)
Conditions: Osteosarcoma;   Sarcoma, Ewing's;   Peripheral Neuroectodermal Tumor
Intervention: Drug: SCH 717454 (19D12)
7 Active, not recruiting Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: mesna;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET photon therapy
8 Recruiting A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent
Conditions: Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET);   Rhabdomyosarcoma;   Leiomyosarcoma;   Adipocytic Sarcoma;   Synovial Sarcoma
Intervention: Biological: IMC-A12
9 Completed Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
Condition: Sarcoma
Interventions: Drug: cyclophosphamide;   Drug: dexrazoxane hydrochloride;   Drug: disaccharide tripeptide glycerol dipalmitoyl;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Procedure: surgical procedure;   Radiation: radiation therapy
10 Terminated Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
Condition: Ewing's Sarcoma
Intervention: Drug: VCR, CTX, ADM; IFO, VP-16
11 Active, not recruiting Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
Condition: Sarcoma
Interventions: Genetic: chromosomal translocation analysis;   Genetic: cytogenetic analysis;   Genetic: mutation analysis;   Genetic: proteomic profiling;   Genetic: reverse transcriptase-polymerase chain reaction
12 Completed New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
Conditions: Ewing's Sarcoma;   Neuroblastoma;   Rhabdomyosarcoma
Interventions: Drug: ADR-529;   Drug: Topotecan;   Drug: G-CSF
13 Active, not recruiting Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
Condition: Sarcoma
Intervention: Drug: exatecan mesylate
14 Active, not recruiting Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
Condition: Ewing's Sarcoma Family of Tumors
Intervention: Drug: CP-751,871
15 Active, not recruiting Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: brachytherapy;   Radiation: radiation therapy
16 Completed Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
Conditions: Kidney Cancer;   Sarcoma
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: radiation therapy
17 Active, not recruiting Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
Conditions: Neuroblastoma;   Sarcoma
Interventions: Biological: aldesleukin;   Biological: autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine;   Biological: therapeutic autologous lymphocytes
18 Completed Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone
Conditions: Metastatic Cancer;   Sarcoma
Interventions: Procedure: peripheral blood stem cell transplantation;   Radiation: holmium Ho 166 DOTMP
19 Withdrawn Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma
Condition: Sarcoma
Interventions: Drug: cyclophosphamide;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Procedure: radiation therapy
20 Active, not recruiting Vincristine, Topotecan, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma
Condition: Sarcoma
Interventions: Biological: bevacizumab;   Drug: cyclophosphamide;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services